Thyroid disorder — all decisions

The Board denied the Veteran's appeal for an initial compensable rating for hypothyroidism, finding that there was no evidence of myxedema or mental disturbance and that the Veteran did not meet the criteria for a higher rating under the applicable diagnostic code.

The Board remands the claim for service connection of thyroid cancer to correct a pre-decisional duty to assist error, as VA failed to obtain relevant personnel records and a new medical opinion.

The Board denied the Veteran's claims for increased ratings and service connection, remanding several issues for further development.

The Board remands the claims for service connection for hypothyroidism, COPD, OSA, sinusitis, and asthma due to a need for additional evidence regarding toxic exposure risk activities (TERA) under the PACT Act.

The Board granted a total disability rating based on individual unemployability (TDIU) solely due to service-connected persistent depressive disorder and special monthly compensation (SMC) based on housebound status.

The Board denied increased ratings for PTSD, diabetes mellitus, type II, and hypothyroidism while granting increased ratings for peripheral neuropathy in the right and left lower extremities, hearing loss (left ear), and a compensable evaluation for scars, burns (2nd degree).

The Veteran was granted a total disability rating based upon individual unemployability (TDIU) from May 13, 2022 to May 2, 2023 due to his service-connected disabilities.

The Board remands the claims for service connection for various conditions, including an acquired psychiatric disorder and radiculopathies of multiple extremities, due to insufficient evidence and the need for additional development.

The Board remands the claims for service connection for heart disorder and hypothyroidism due to pre-decision duty to assist errors.

The Board granted an effective date of August 8, 2018, for the award of service connection for hypothyroidism.

The Board remands the claim for service connection for hypothyroidism to schedule a new VA examination with an opinion on whether the Veteran's condition is related to her service, including exposure to burn pits.

The Board remands the claims for service connection and increased ratings due to pre-decisional errors in not verifying periods of active duty, active duty for training, and inactive duty for training with various reserve units and in obtaining adequate medical examinations.

The Board dismissed several claims for service connection and a higher rating, including those for hypothyroidism, right achilles tendon strain, tinnitus, and erectile dysfunction.

The Board remands the service connection claim for thyroid disability due to a pre-decisional duty to assist error in obtaining missing private treatment records.

The Board denied the veteran's claims for increased ratings and service connection, finding that the evidence did not support a higher rating for tinnitus or a compensable rating for bilateral hearing loss. The claim for an acquired psychiatric disability was also denied as there was no current diagnosis of PTSD or other mental health condition.

The Board granted an effective date of April 26, 2021, but no earlier, for service connection for coronary artery disease and a 30 percent rating from January 30, 2023, for hiatal hernia with Barrett's metaplasia with gastroesophageal reflux disease (GERD), while denying an effective date prior to August 10, 2022, for service connection for hypertension.

The Board remands the claims for service connection for alpha thalassemia, anemia, and hypothyroidism as secondary to anemia due to a pre-decisional duty to assist error.

The Veteran withdrew his appeal in its entirety, and the Board has no jurisdiction to review the appeal.

The Board granted service connection for fibrodysplasia and denied service connection for bone cancer. The claim for a thyroid disability was remanded.

The Board denied the veteran's claims for service connection for diabetes mellitus type II, hypertension, hypothyroidism, a heart disorder, and prostate cancer as new and relevant evidence was not received to support readjudication of these claims.